RFK Jr. Says New HHS Decisions No Longer Required to Be Open for Public Comment

Follow Drugslib on

Medically reviewed by Drugs.com.

By Stephanie Brown HealthDay Reporter

MONDAY, March 3, 2025 -- In a policy statement published today in the Federal Register, Robert F. Kennedy Jr., secretary of the U.S. Department of Health and Human Services, has rescinded the current policy of requiring new rules and regulations to be open to public comment before they are implemented by the agency.

It has been the practice of the department, under the Administrative Procedure Act, to allow the public an opportunity to voice their support or opposition to government proposals via submitted comments. Since 1971, the Richardson Waiver has been in place to impose notice-and-comment periods above and beyond those required under the Administrative Procedure Act.

The summary of the new policy states: "The Department of Health and Human Services' (the Department) Immediate Office of the Secretary is rescinding the policy on Public Participation in Rule Making (Richardson Waiver) and re-aligning the Department's rulemaking procedures with the Administrative Procedure Act."

The department says it is revoking the little-known waiver because the public participation process imposes too many responsibilities on the department, "beyond the maximum" requirements of the law. Those obligations "are contrary to the efficient operation of the department, and impede the department's flexibility to adapt quickly to legal and policy mandates," Kennedy wrote in the document.

However, at the conclusion of the document, Kennedy states that "the Department will continue to follow notice and comment rulemaking procedures in all instances in which it is required to do so by the statutory text of the Administrative Procedure Act."

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-03-04 12:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords